ProCE Banner Activity

Overcoming BTK Inhibitor Resistance and Combination Strategies

Slideset Download
Download these slides from our ASH 2019 live satellite symposium on overcoming resistance to BTK inhibitors to review the most current clinical data on treating patients with CLL.

Released: December 06, 2019

Expiration: December 04, 2020

No longer available for credit.

Share

Faculty

Jan A. Burger

Jan A. Burger, MD, PhD

Professor of Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.

Loxo Oncology subsidiary of Eli Lilly

Faculty Disclosure

Primary Author

Jan A. Burger, MD, PhD

Professor of Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Jan A. Burger, MD, PhD, has disclosed that he has received funds for research support from BeiGene, Gilead Sciences, and Pharmacyclics and speakers’ fees from Janssen.